Search Results - "Moon, H.S"

Refine Results
  1. 1

    Biodegradability and biodegradation rate of poly(caprolactone)-starch blend and poly(butylene succinate) biodegradable polymer under aerobic and anaerobic environment by Cho, H.S., Moon, H.S., Kim, M., Nam, K., Kim, J.Y.

    Published in Waste management (Elmsford) (01-03-2011)
    “…The biodegradability and the biodegradation rate of two kinds biodegradable polymers; poly(caprolactone) (PCL)-starch blend and poly(butylene succinate) (PBS),…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Use of autotrophic sulfur-oxidizers to remove nitrate from bank filtrate in a permeable reactive barrier system by Moon, H.S., Ahn, K.-H., Lee, S., Nam, K., Kim, J.Y.

    Published in Environmental pollution (1987) (01-06-2004)
    “…This study was conducted to evaluate the potential applicability of an in situ biological reactive barrier system to treat nitrate-contaminated bank filtrate…”
    Get full text
    Journal Article
  7. 7

    Changes in Genetic Diversity of U.S. Flue‐Cured Tobacco Germplasm over Seven Decades of Cultivar Development by Moon, H.S., Nicholson, J.S., Heineman, A., Lion, K., Hoeven, R., Hayes, A.J., Lewis, R.S.

    Published in Crop science (01-03-2009)
    “…Plant breeding methodologies have been applied to flue‐cured tobacco (Nicotiana tabacum L.) for approximately seven decades. As has been observed in several…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    A multicenter phase II study of belotecan, new camptothecin analogue, in patients with previously untreated extensive stage disease small cell lung cancer by Kim, S.J, Kim, J.S, Kim, S.C, Kim, Y.K, Kang, J.Y, Yoon, H.K, Song, J.S, Lee, S.H, Moon, H.S, Kim, J.W, Kim, K.H, Kim, C.H, Shim, B.Y, Kim, H.K

    Published in Lung cancer (Amsterdam, Netherlands) (01-06-2010)
    “…Abstract Belotecan (Camtobell, CKD602) is a new camptothecin derivative antitumor agent that belongs to the topoisomerase inhibitors. The aim of this phase II…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20